Cleveland Clinic research finds that chronic kidney disease is widely prevalent in patients with pulmonary hypertension, and that lower levels of kidney function are associated with an increased risk of death.
Six percent of Americans have both chronic kidney disease and metabolic syndrome. A Cleveland Clinic study looks for associations among metabolic syndrome, end stage renal disease and death.
A look into Cleveland Clinic’s chronic kidney disease registry uncovers risks of increasing levels of serum alkaline phosphatase
Chronic kidney disease patients are less likely to receive optimal management of heart failure despite being more likely to die of cardiovascular disease. Cardiac resynchronization therapy may improve their outcomes
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Examination of a national database uncovers a disparity in outcomes in weekend vs. weekday admissions, even when adjusting for comorbidity or hospital bed size…